MedKoo Cat#: 413933 | Name: Droprenilamine HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Droprenilamine HCl is a biochemical.

Chemical Structure

Droprenilamine HCl
Droprenilamine HCl
CAS#59182-63-7 (HCl)

Theoretical Analysis

MedKoo Cat#: 413933

Name: Droprenilamine HCl

CAS#: 59182-63-7 (HCl)

Chemical Formula: C24H34ClN

Exact Mass:

Molecular Weight: 371.99

Elemental Analysis: C, 77.49; H, 9.21; Cl, 9.53; N, 3.77

Price and Availability

Size Price Availability Quantity
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Droprenilamine HCl; Droprenilamine hydrochloride; MG8926; MG-8926; MG 8926; Valcor
IUPAC/Chemical Name
Benzenepropanamine, N-(2-cyclohexyl-1-methylethyl)-phenyl-, hydrochloride (8CI)
InChi Key
DHCUYKDNYXYZLM-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H33N.ClH/c1-20(19-21-11-4-2-5-12-21)25-18-10-16-23-15-8-9-17-24(23)22-13-6-3-7-14-22;/h3,6-9,13-15,17,20-21,25H,2,4-5,10-12,16,18-19H2,1H3;1H
SMILES Code
CC(NCCCC1=CC=CC=C1C2=CC=CC=C2)CC3CCCCC3.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Droprenilamine HCl is a biochemical.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 371.99 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Nakanishi H, Matsuoka I, Ono T, Yoshida H, Uchibori T, Kogi K. Effect of a prenylamine analog (MG8926) on spontaneous action potentials in isolated rabbit sinoatrial node. Fukushima J Med Sci. 1996 Dec;42(1-2):1-10. PubMed PMID: 9127964. 2: Baratta L, Mastrocola C, Lanciotti G, Petrosillo N, Tubani L, Iannetti A, Avella A. [Comparison of 2 groups of patients with ischemic cardiopathy treated with droprenylamine and prenylamine]. Minerva Cardioangiol. 1982 Jun;30(6):299-302. Italian. PubMed PMID: 7133418. 3: Rengo F, Trimarco B, Volpe M, Ricciadelli B, Morrone G, De Simone A, Condorelli M. [Clinical evaluation of a new antianginal drug: droprenylamine]. G Ital Cardiol. 1980;10(4):473-5. Italian. PubMed PMID: 7002693. 4: Baratta L, Mastrocola C, Petrosillo N, Guerrieri P, Leone G, Lanciotti G. [Clinical and electrocardiographic evaluation of the effectiveness of droprenylamine in patients with ischemic cardiopathy]. Minerva Cardioangiol. 1979 Nov;27(11):709-18. Italian. PubMed PMID: 545178.